Volume 35 Issue 4
Jul.  2014
Turn off MathJax
Article Contents

Xiao-Lei AN, Fa-Dao TAI. AVP and Glu systems interact to regulate levels of anxiety in BALB/cJ mice. Zoological Research, 2014, 35(4): 319-325. doi: 10.13918/j.issn.2095-8137.2014.4.319
Citation: Xiao-Lei AN, Fa-Dao TAI. AVP and Glu systems interact to regulate levels of anxiety in BALB/cJ mice. Zoological Research, 2014, 35(4): 319-325. doi: 10.13918/j.issn.2095-8137.2014.4.319

AVP and Glu systems interact to regulate levels of anxiety in BALB/cJ mice

doi: 10.13918/j.issn.2095-8137.2014.4.319
  • Received Date: 2013-06-07
  • Rev Recd Date: 2013-12-25
  • Publish Date: 2014-07-08
  • Whilethe roles of glutamic acid (Glu), arginine vasopressin (AVP) and their respective receptors in anxiety have been thoroughly investigated, the effects of interactions among Glu, N-methyl-D-aspartic acid (NMDA) receptor, AVP and a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor on anxiety are still unclear. In the present study, the agonist and antagonist of the NMDA receptor and AMPA receptor, as well as the antagonist of AVP V1 receptor (V1aR) were introduced into BALB/cJ mice by intracerebroventricular microinjection, and the anxiety-like behaviors of the mice were evaluated by open field and elevated plus-maze tests. Compared with C57BL/6 mice, BALB/cJ mice displayed higher levels of anxiety-like behavior. Significant anxiolytic effects were found in the NMDA receptor antagonist (MK-801) and the AMPA receptor or V1aR antagonist (SSRI49415), as well as combinations of AVP/MK-801 and SSRI49415/DNQX. These results indicated that anxiety-like behaviors expressed in BALB/CJ mice may be due to a coordination disorder among glutamate, NMDA receptor, AMPA receptor, AVP and V1aR, resulting in the up-regulation of the NMDA receptor and V1aR and down-regulation of the AMPA receptor. However, because the AMPA receptor can execute its anxiolytic function by suppressing AVP and V1aR, we cannot exclude the possibility of the NMDA receptor being activated by AVP acting on V1aR.
  • 加载中
  • [1] An XL, Tai FD. 2010. Effects of estradiol and clomifene citrate on behavior of BALB/cJ mice. Journal of Shaanxi Normal University: Natural Science Edition, 38(5): 82-86. (in Chinese)
    [2] Appenrodt E, Schwarzberg H. 2000. Central vasopressin administration failed to influence anxiety behavior after pinealectomy in rats. Physiology & Behavior, 68(5): 735-739.
    [3] Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB. 1999. The role of corticotropin-releasing factor in depression and anxiety disorders. Journal of Endocrinology, 160(1): 1-12.
    [4] Bales KL, Kim AJ, Lewis-Reese AD, Sue Carter C. 2004. Both oxytocin and vasopressin may influence alloparental behavior in male prairie voles. Hormones and Behavior, 45(5): 354-361.
    [5] Beck KD, Luine VN. 2002. Sex differences in behavioral and neurochemical profiles after chronic stress: role of housing conditions. Physiology & Behavior, 75(5): 661-673.
    [6] Bergink V, Westenberg H G M. Glutamate and anxiety. European Neuropsychopharmacology, 2004, 14(3): 175-183.
    [7] Chen Q, He ST, Hu XL, Yu J, Zhou Y, Zheng J, Zhang SL, Zhang C, Duan WH, Xiong ZQ. 2007. Differential roles of NR2A-and NR2B-containing NMDA receptors in activity-dependent brain-derived neurotrophic factor gene regulation and limbic epileptogenesis. Journal of Neuroscience, 27(3): 542-552.
    [8] Chen Z, Xu WP, Wei W. 2008. Research progress of neuroendocrinology depression. Shandong Medicine Journal, 48(37): 110-111. (in Chinese)
    [9] Fontán-Lozano A, Sáez-Cassanelli JL, Inda MC, de los Santos-Arteaga M, Sierra-Domínguez SA, López-Lluch G, Delgado-García JM, Carrión AM. 2007. Caloric restriction increases learning consolidation and facilitates synaptic plasticity through mechanisms dependent on NR2B subunits of the NMDA receptor. Journal of Neuroscience, 27(38): 10185-10195.
    [10] Hashimoto K. 2011. The role of glutamate on the action of antidepressants. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35(7): 1558-1568.
    [11] Herman JP, Cullinan WE. 1997. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends in Neurosciences, 20(2): 78-84.
    [12] Iwanaga M, Ohno M, Katoh A, Ohbuchi T, Ishikura T, Fujihara H, Nomura M, Hachisuka K, Ueta Y. 2011. Upregulation of arginine vasopressin synthesis in the rat hypothalamus after kainic acid-induced seizures. Brain Research, 1424: 1-8.
    [13] Joëls M, Urban IJ. 1984. Arginine vasopressin enhances the responses of lateral septal neurons in the rat to excitatory amino acids and fimbria-fornix stimuli. Brain Research, 311(2): 201-209.
    [14] Katz RJ. 1982. Animal model of depression: pharmacological sensitivity of a hedonic deficit. Pharmacology Biochemistry and Behavior, 16(6): 965-968.
    [15] Kim JJ, Diamond DM. 2002. The stressed hippocampus, synaptic plasticity and lost memories. Nature Reviews Neuroscience, 3(6): 453-462.
    [16] Kole MHP, Costoli T, Koolhaas JM, Fuchs E. 2004. Bidirectional shift in the cornu ammonis 3 pyramidal dendritic organization following brief stress. Neuroscience, 125(2): 337-347.
    [17] Koloski NA, Talley NJ, Boyce PM. 2002. Epidemiology and health care seeking in the functional GI disorders: a population-based study. The American Journal of Gastroenterology, 97(9): 2290-2299.
    [18] MacMaster FP, Mirza Y, Szeszko PR, Kmiecik LE, Easter PC, Taormina SP, Lynch M, Rose M, Moore GJ, Rosenberg DR. 2008. Amygdala and hippocampal volumes in familial early onset major depressive disorder. Biological Psychiatry, 63(4): 385-390.
    [19] Maeng S, Zarate CA Jr, Du J, Schloesser RJ, McCammon J, Chen G, Manji HK. 2008. Cellular mechanisms underlying the antidepressant effects of ketamine: role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic acid receptors. Biological Psychiatry, 63(4): 349-352.
    [20] Maione S, Vitagliano S, Berrino L, Lampa E, Rossi F. 1992. Participation of arginine vasopressin-mediated and adrenergic system-mediated mechanisms in the hypertension induced by intracerebroventricular administration of NMDA in freely moving rats. Neuropharmacology, 31: 403-407.
    [21] Matthews K, Forbes N, Reid IC. 1995. Sucrose consumption as an hedonic measure following chronic unpredictable mild stress. Physiology & Behavior, 57(2): 241-248.
    [22] McEwen BS. 1999. Stress and hippocampal plasticity. Annual Review of Neuroscience, 22: 105-122.
    [23] McKinnon MC, Yucel K, Nazarov A, MacQueen GM. 2009. A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. Journal of Psychiatry & Neuroscience, 34(1): 41-54.
    [24] Müller MB, Holsboer F. 2006. Mice with mutations in the HPA-System as models for symptoms of depression. Biological Psychiatry, 59(12): 1104-1115.
    [25] Patchev VK, Karalis K, Chrousos GP. 1994. Effects of excitatory amino acid transmitters on hypothalamic corticotropin-releasing hormone (CRH) and arginine-vasopressin (AVP) release in vitro: implications in pituitary-adrenal regulation. Brain Research, 633(1-2): 312-316.
    [26] Paxinos G, Franklin KBJ. The Mouse Brain in Stereotaxic Coordinates. Academic Press: San Diego, 2004.
    [27] Rios Valentim SJ Jr, Gontijo AVL, Peres MD, de Melo Rodrigues LC, Nakamura-Palacios EM. 2009. D1 dopamine and NMDA receptors interactions in the medial prefrontal cortex: modulation of spatial working memory in rats. Behavioural Brain Research, 204(1): 124-128.
    [28] Sapolsky RM. 2000. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biological Psychiatry, 48(8): 755-765.
    [29] Skolnick P. 1999. Antidepressants for the new millennium. European Journal of Pharmacology, 375(1-3): 31-40.
    [30] Teuchner B, Dimmer A, Troger J, Fischer-Colbrie R, Schmid E, Kieselbach G, Dietrich H, Bechrakis N. 2010. Secretoneurin and the tachykinins substance P and neurokinin-A/B in NMDA-induced excitotoxicity in the rat retina. Regulatory Peptides, 165(1): 123-127.
    [31] Valenzuela-Harrington M, Gruart A, Delgado-García JM. 2007. Contribution of NMDA receptor NR2B subunit to synaptic plasticity during associative learning in behaving rats. European Journal of Neuroscience, 25(3): 830-836.
    [32] Xu SF. 1999. Neurobiology. 2nd ed. Shanghai: Fudan University Press, 457.
    [33] Yamaguchi K, Watanabe K. 2005. Anteroventral third ventricular N-methyl-D-aspartate receptors, but not metabotropic glutamate receptors are involved in hemorrhagic AVP secretion. Brain Research Bulletin, 66(1): 59-69.
    [34] Yamaguchi K, Yamada T. 2006. Involvement of anteroventral third ventricular AMPA/kainate receptors in both hyperosmotic and hypovolemic AVP secretion in conscious rats. Brain Research Bulletin, 71(1-3): 183-92.
    [35] Yayou K, Sato Y, Ito S, Nakamura M. 2008. Comparison between the central effects of CRH and AVP in steers. Physiology & Behavior, 93(3): 537-545.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(635) PDF downloads(1140) Cited by()

Related
Proportional views

AVP and Glu systems interact to regulate levels of anxiety in BALB/cJ mice

doi: 10.13918/j.issn.2095-8137.2014.4.319

Abstract: Whilethe roles of glutamic acid (Glu), arginine vasopressin (AVP) and their respective receptors in anxiety have been thoroughly investigated, the effects of interactions among Glu, N-methyl-D-aspartic acid (NMDA) receptor, AVP and a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor on anxiety are still unclear. In the present study, the agonist and antagonist of the NMDA receptor and AMPA receptor, as well as the antagonist of AVP V1 receptor (V1aR) were introduced into BALB/cJ mice by intracerebroventricular microinjection, and the anxiety-like behaviors of the mice were evaluated by open field and elevated plus-maze tests. Compared with C57BL/6 mice, BALB/cJ mice displayed higher levels of anxiety-like behavior. Significant anxiolytic effects were found in the NMDA receptor antagonist (MK-801) and the AMPA receptor or V1aR antagonist (SSRI49415), as well as combinations of AVP/MK-801 and SSRI49415/DNQX. These results indicated that anxiety-like behaviors expressed in BALB/CJ mice may be due to a coordination disorder among glutamate, NMDA receptor, AMPA receptor, AVP and V1aR, resulting in the up-regulation of the NMDA receptor and V1aR and down-regulation of the AMPA receptor. However, because the AMPA receptor can execute its anxiolytic function by suppressing AVP and V1aR, we cannot exclude the possibility of the NMDA receptor being activated by AVP acting on V1aR.

Xiao-Lei AN, Fa-Dao TAI. AVP and Glu systems interact to regulate levels of anxiety in BALB/cJ mice. Zoological Research, 2014, 35(4): 319-325. doi: 10.13918/j.issn.2095-8137.2014.4.319
Citation: Xiao-Lei AN, Fa-Dao TAI. AVP and Glu systems interact to regulate levels of anxiety in BALB/cJ mice. Zoological Research, 2014, 35(4): 319-325. doi: 10.13918/j.issn.2095-8137.2014.4.319
Reference (35)

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return